北京美科美生物公司代理bio QControl

SERAQ CONTROLS FOR VIRAL SEROLOGY ASSAYS
SERAQ CONTROLS FOR SYPHILIS ASSAYS
VIRAQ CHECK AND TREND CONTROLS FOR HBV/HCV/HIV NAT ASSAYS
VIRAQ CHECK CONTROLS FOR NON-ENVELOPED VIRUS NAT ASSAYS
VIRAQ CHECK CONTROLS FOR ARBOVIRUS NAT ASSAYS
ANALYTICAL SENSITIVITY PANELS FOR HBV-DNA ASSAYS
ANALYTICAL SENSITIVITY PANELS FOR HCV-RNA ASSAYS
ANALYTICAL SENSITIVITY PANELS FOR HIV-RNA ASSAYS
NON-ENVELOPED VIRUS STANDARD DILUTION PANELS
MULTIPLE VIRAL GENOTYPE REFERENCE PANELS FOR VIRAL NAT ASSAYS
ARBOVIRUS STANDARD DILUTION PANELS
VIRAQ QUANT CONTROLS FOR VIRAL LOAD ASSAYS
LINEARITY PANELS FOR VIRAL LOAD ASSAYS


1992年，我们接受了为病毒性NAT实验室组织第一次国际水平研究的挑战。这些研究的结果表明，迫切需要对这些测试方法进行标准化和质量控制。从那时起，我们通过提供参考面板和根据稳定病毒标准制备的对照品，努力为血液筛查分析的评估做出贡献。现在，将近30年后，我们已经证明，我们的深冻血浆标准参考样品的制造过程在多种环境下提供了一致的质量控制产品。多年来，我们继续进一步描述我们的标准，证明我们在核酸拷贝中的校准接近真实的病毒粒子数。这为了解血液筛选试验在降低病毒传播风险中的益处提供了基础。我们的参考标准和统计工具用于评估血液筛查分析，旨在为血液筛查分析的上市后监测系统提供必要和必要的组成部分。通过提供这些产品和服务，我们公司希望为促进和改善血液安全做出贡献。
In 1992 we took on the challenge of organising the first international proficiency study for viral NAT laboratories. The outcome of these studies demonstrated an urgent need for standardisation and quality control of these test methods. Since then we have endeavoured to make a contribution to evaluation of blood screening assays by providing reference panels and controls prepared from stable viral standards. Now, almost thirty years later, we have demonstrated that our manufacturing process of reference sample from deep frozen plasma standards, has provided consistent quality control products in multiple settings. Over the years we have continued to further characterise our standards, demonstrating that our calibration in nucleic acid copies are close to true virion numbers. This provides a foundation for understanding the benefit of blood screening assays in reducing viral transmission risk. With our reference standards and statistical tools for evaluation of blood screening assays we aim to provide the necessary and essential components of a post-market surveillance system of blood screening assays. With the provision of these products and services, our company hopes to contribute to, and improve blood safety.